A few studies in this review found stronger associations of CRP with breast cancer risk in the first few years of follow-up, which might be more indicative of consequence rather than causes of underlying cancer [26,27], but the meta-analysis by Chan et al. found that positive associations remained in studies that excluded early years of follow-up [23]. Here, CRP is linked to breast carcinoma.